top of page

Absci

​

Absci is unlocking the potential of next-generation biologics by harnessing deep learning AI and synthetic biology to explore a vast therapeutic sequence space inaccessible to conventional discovery methods.

NASDAQ: ABSI

Landos Biopharma

​

Landos Biopharma Inc is a clinical-stage company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases.

​

Acquired by Abbvie

ACQUIRED

Pipeline Therapeutics

​

Pipeline Therapeutics is focused on  developing first-in-class molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair.

​

NASDAQ: CTNM

Contineum Logo.jpg

Ribbon Biolabs

​

Ribbon Biolabs is a synthetic biology company advancing a new technology for the automated synthesis of long DNA molecules to enable innovation in the life sciences.

Crown Bioscience

​

CrownBio is helping provide clarity of action in the fight against cancer and diabetes.

 

 

Acquired by JSR Life Sciences

Crown_Bioscience_Logo_-_TEAL.jpg

ACQUIRED

Tangible Science

​

Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases. Tangible's technology has the potential to be used from consumer contact lens to smart contact lens.

HV Stealth Co​

​

Focus in a carrier technology for therapies in Diatbetes, Chronic Kidney Disease and •Conditions affecting the digestive systems (e.g., celiac disease, Crohn’s disease, UC)

Helicase Ventures logo edited.png

HV Stealth Co.

Totient Bio

​

Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. Acquired by Absci

ACQUIRED

X-Vax

​

X-VAX is on a quest to defeat herpes by harnessing the power of antibodies that mediate the killing of infected cells.

Ausnutria

​

Ausnutria is a global dutch company specializing in infant care products from new infant formulas and probiotics. Acquired by Yili

ACQUIRED

Lumosa Therapeutics

​

Lumosa Therapeutics is a clinical-stage pharmaceutical company developing novel therapies and solutions for neurological and oncological diseases

Lumosa.jpg

IPO

TOT Biopharm

​

TOT Biopharm is dedicated to developing innovative oncology drugs.

tot-biopharm.jpg

IPO

Medeon

​

Medeon designs, develops, and manufactures high-value, high-impact medical device solutions that will transform healthcare.

IPO

* Investments made prior to Helicase Venture spinout

©2024 by Helicase Venture and affiliates. All rights reserved

  • linkedin
bottom of page